Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog.

about

Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog.

Item

http://www.wikidata.org/entity/Q38659292

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targeted molecular radiotherap ...... kyl-phospholipid ether analog.

@en

type

Item

label

Targeted molecular radiotherap ...... kyl-phospholipid ether analog.

@en

prefLabel

Targeted molecular radiotherap ...... kyl-phospholipid ether analog.

@en

P1476

Targeted molecular radiotherap ...... kyl-phospholipid ether analog.

@en

P2093

Alexander E Boruch

http://www.w3.org/2001/XMLSchema#string

Ankita Shahi

http://www.w3.org/2001/XMLSchema#string

Bryan Bednarz

http://www.w3.org/2001/XMLSchema#string

Dana C Baiu

http://www.w3.org/2001/XMLSchema#string

Ian R Marsh

http://www.w3.org/2001/XMLSchema#string

Jamey P Weichert

http://www.w3.org/2001/XMLSchema#string

Justin J Jeffery

http://www.w3.org/2001/XMLSchema#string

Lance Hall

http://www.w3.org/2001/XMLSchema#string

Mario Otto

http://www.w3.org/2001/XMLSchema#string

Qianqian Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies

Random-effects models for longitudinal data

Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.

177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.

A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.

National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing

A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety.

Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.

Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma

Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.

P31

scholarly article

P356

10.2967/JNUMED.117.193748

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28747518

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5807534

http://www.w3.org/2001/XMLSchema#string